SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950159-17-000045
Filing Date
2017-02-14
Accepted
2017-02-14 09:00:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. SCHEDULE 13G/A cempra13ga.htm SC 13G/A 86811
  Complete submission text file 0000950159-17-000045.txt   88458
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86624 | Film No.: 17602836
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A